|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: VIROPHARMA INC, 10-Q, EX-10.33, 2000-11-13 |
Next: AVERY COMMUNICATIONS INC, 10QSB, 2000-11-13 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<S> <C> <C>
<PERIOD-TYPE> 3-MOS 9-MOS
<FISCAL-YEAR-END> DEC-31-2000 DEC-31-2000
<PERIOD-START> JUL-01-2000 JAN-01-2000
<PERIOD-END> SEP-30-2000 SEP-30-2000
<CASH> 4,623,763 4,623,763
<SECURITIES> 208,147,198 208,147,198
<RECEIVABLES> 65,750 65,750
<ALLOWANCES> 0 0
<INVENTORY> 0 0
<CURRENT-ASSETS> 218,244,139 218,244,139
<PP&E> 6,256,682 6,256,682
<DEPRECIATION> 1,831,831 1,831,831
<TOTAL-ASSETS> 228,782,887 228,782,887
<CURRENT-LIABILITIES> 11,068,994 11,068,994
<BONDS> 0 0
0 0
2,300 2,300
<COMMON> 30,386 30,386
<OTHER-SE> 34,056,207 34,056,207
<TOTAL-LIABILITY-AND-EQUITY> 228,782,887 228,782,887
<SALES> 0 0
<TOTAL-REVENUES> 250,000 1,750,000
<CGS> 0 0
<TOTAL-COSTS> 0 0
<OTHER-EXPENSES> 14,142,021 29,143,225
<LOSS-PROVISION> 0 0
<INTEREST-EXPENSE> 2,721,143 6,391,611
<INCOME-PRETAX> (12,724,643) (24,883,815)
<INCOME-TAX> 0 0
<INCOME-CONTINUING> (12,724,643) (24,883,815)
<DISCONTINUED> 0 0
<EXTRAORDINARY> 0 0
<CHANGES> 0 0
<NET-INCOME> (12,724,643) (24,883,815)
<EPS-BASIC> (.85) (1.68)
<EPS-DILUTED> (.85) (1.68)
</TABLE>
|
|